|
![]() |
|||
|
||||
OverviewThis book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities. Full Product DetailsAuthor: Zaheer-Ud-Din BabarPublisher: Springer International Publishing AG Imprint: Adis Edition: 2015 ed. Dimensions: Width: 15.50cm , Height: 2.40cm , Length: 23.50cm Weight: 7.568kg ISBN: 9783319121680ISBN 10: 3319121685 Pages: 411 Publication Date: 18 December 2014 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsIntroduction.- Reference pricing strategies.- Differential pricing.- Prices of vaccines.ReviewsThis book is a collection of national case studies about pharmaceutical pricing policy. ... this book offers a wealth of examples to consider, especially for low- and middle-income countries that are in the process of changing or establishing health insurance programs. Having a consolidated reference source, such as this book, for academics interested in the field of policy analysis will obviously be very useful. (Suzanne Rose Hill, PharmacoEconomics, Vol. 34 (3), March, 2016) “This book is a collection of national case studies about pharmaceutical pricing policy. … this book offers a wealth of examples to consider, especially for low- and middle-income countries that are in the process of changing or establishing health insurance programs. Having a consolidated reference source, such as this book, for academics interested in the field of policy analysis will obviously be very useful.” (Suzanne Rose Hill, PharmacoEconomics, Vol. 34 (3), March, 2016) Author InformationTab Content 6Author Website:Countries AvailableAll regions |